Oral Fluorescein Angiography for the Diagnosis of Papilledema Versus Pseudopapilledema in Children

Am J Ophthalmol. 2023 Jan:245:8-13. doi: 10.1016/j.ajo.2022.08.020. Epub 2022 Sep 6.

Abstract

Purpose: To evaluate the accuracy and safety of oral fluorescein angiography (OFA) in differentiating papilledema from pseudopapilledema in pediatric patients.

Design: Retrospective evaluation of a diagnostic test.

Methods: We retrospectively reviewed medical records of all children ≤18 years of age who presented to the Arkansas Children's Hospital between May 2018 and August 2021 with suspected optic disc (OD) swelling that had OFA and images >30 minutes after oral ingestion. Two masked specialists interpreted the images as either OD leakage, no leakage, or borderline leakage. Optic disc swelling was graded clinically according to the Frisen grading scale (0-5). We compared OFA images to the final clinical diagnosis and calculated the accuracy of the test as follows: (number of eyes correctly identified as papilledema [true positive] + number of eyes correctly identified as pseudopapilledema [true negative]) / (total number of eyes) × 100%.

Results: Forty-five patients (90 eyes) were included, 11 patients with papilledema and 34 with pseudopapilledema. The mean age was 14.1 ± 3.5 years; 66.7% were female. The accuracy of OFA was 62% for reviewer 1 and 69% for reviewer 2. No ocular or systemic side effects after OFA were observed. There was substantial agreement (k = 0.779) between both reviewers in grading the OFA images.

Conclusion: OFA cannot definitively distinguish papilledema from pseudopapilledema in children and should be interpreted in conjunction with other clinical findings.

MeSH terms

  • Adolescent
  • Child
  • Female
  • Fluorescein Angiography / methods
  • Humans
  • Male
  • Papilledema* / diagnosis
  • Retinal Ganglion Cells
  • Retrospective Studies
  • Tomography, Optical Coherence / methods

Supplementary concepts

  • Pseudopapilledema